SANUWAVE Health, Inc.
SNWV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.08 | -0.01 | 0.02 | 0.09 |
| FCF Yield | 1.91% | -44.02% | -128.89% | -7.87% |
| EV / EBITDA | -7.12 | -4.42 | 10.95 | -6.02 |
| Quality | ||||
| ROIC | 41.45% | 4.96% | -271.65% | 116.35% |
| Gross Margin | 75.23% | 70.41% | 74.13% | 61.68% |
| Cash Conversion Ratio | -0.08 | 0.18 | 1.67 | 0.24 |
| Growth | ||||
| Revenue 3-Year CAGR | 24.92% | 16.17% | 60.40% | 132.98% |
| Free Cash Flow Growth | 143.30% | 71.90% | -132.73% | 45.67% |
| Safety | ||||
| Net Debt / EBITDA | -0.92 | -3.29 | 8.34 | -1.35 |
| Interest Coverage | 0.40 | -0.03 | -0.63 | -1.99 |
| Efficiency | ||||
| Inventory Turnover | 1.95 | 2.05 | 4.99 | 4.79 |
| Cash Conversion Cycle | 56.24 | -107.26 | -209.83 | -415.69 |